Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health    CVS

CVS HEALTH (CVS)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

CVS Health : Revenue Rises as It Pursues Aetna

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/06/2017 | 02:11pm CEST
By Cara Lombardo 

Stronger pharmacy sales boosted CVS Health Corp.'s revenue in its latest quarter as the drugstore chain weighs a purchase of health insurer Aetna Inc., a move that would bolster its prescription business.

CVS's third-quarter revenue rose 3.5% to $46.2 billion, matching what analysts polled by Thomson Reuters expected.

The Wall Street Journal reported last month that the drugstore giant is in talks to buy Aetna for $66 billion, according to people familiar with the matter, following a six-month hunt for a deal partner. The move would strengthen CVS's position in negotiations with drugmakers, and analysts are likely to question company executives about the potential tie-up on a Monday earnings call.

People familiar with the discussions have said it could take until the end of the year to solidify a deal, if it happens.

In its latest quarter, sales in CVS's pharmacy-services segment increased 8.1% to $32.9 billion, driven by growth in pharmacy network claims and specialty pharmacy volume. Retail segment sales, meanwhile, slipped 2.7% to $19.6 billion, hurt by falling same-store sales.

The company also recorded $55 million in expenses related to the recent string of hurricanes, with most of it impacting the retail segment.

Overall for the quarter, CVS reported a profit of $1.3 billion, or $1.26 a share, compared with $1.5 billion, or $1.43 a share, a year ago.

Excluding one-time items, the Woonsocket, R.I.-based company earned $1.50 a share, compared with $1.64 a year ago. Analysts had expected adjusted earnings per share of $1.48 on net income of $1.5 billion.

The company also narrowed its full-year earnings guidance and raised the midpoint. It now expects adjusted earnings of $5.87 to $5.91. It previously guided a range of $5.83 to $5.93.

CVS shares, down 12% this year, rose less than 1% premarket on low volume.

Write to Cara Lombardo at [email protected]

Stocks mentioned in the article
ChangeLast1st jan.
AETNA 0.06% 177.2 Delayed Quote.-1.92%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH
12:39pCVS HEALTH : MSDE DORS, CVS Health to Honor First Graduates of Retail Training P..
AQ
03:32aGlenview's Robbins says talk of Amazon's entering pharma is overblown
RE
04/23Humana, PE firms to buy hospice operator Curo Health for $1.4 billion
RE
04/20CVS HEALTH CORPORATION : To Hold First Quarter 2018 Conference Call
PR
04/20CVS PHARMACY : Offering Hepatitis A Vaccine to Kentuckians Following an Increase..
PR
04/20CVS HEALTH : Ex-dividend day for
FA
04/19CVS HEALTH : Expands Safe Drug Disposal at CVS Pharmacy Locations in Ohio to Hel..
PR
04/19CVS PHARMACY : Launches First Campaign Featuring Unaltered Beauty Imagery
PR
04/19CVS HEALTH : EX-Dividend Schedule: CVS Health Has a Dividend Yield of 3.03%; Wil..
AC
04/18CVS HEALTH : Phoenix VA Health Care System, TriWest and CVS Health Mark First An..
PR
More news
News from SeekingAlpha
04/23OAKMARK EQUITY AND INCOME FUND : Q1 2018 
04/21THE PASSIVE DGI CORE PORTFOLIO : Income, Safety, And Growth 
04/20Vilas Fund, LP Q1 '18 Letter To Partners - #28 Since Inception, Long Pharma 
04/1910 Dividend Growth Stocks For April 2018 
04/19Jelly Beans, Group Think, And Greenblatt's Magic Formula 
Financials ($)
Sales 2018 189 B
EBIT 2018 10 003 M
Net income 2018 5 761 M
Debt 2018 20 873 M
Yield 2018 3,28%
P/E ratio 2018 12,08
P/E ratio 2019 10,75
EV / Sales 2018 0,46x
EV / Sales 2019 0,43x
Capitalization 66 066 M
Chart CVS HEALTH
Duration : Period :
CVS Health Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Technical analysis trends CVS HEALTH
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 87,9 $
Spread / Average Target 34%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH-10.18%66 066
WALGREENS BOOTS ALLIANCE-11.98%63 387
EXPRESS SCRIPTS HOLDING CO0.74%41 267
MCKESSON CORPORATION-4.89%30 177
AMERISOURCEBERGEN-2.12%19 742
CARDINAL HEALTH1.31%19 534